New heart pump trial offers hope for advanced heart failure patients

NCT ID NCT06907017

Recruiting now Disease control Sponsor: CorWave Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new heart pump (CorWave LVAS) in 20 people with advanced heart failure. The pump helps the heart pump blood when it is too weak. The goal is to see if the device is safe and works well, with a focus on survival and avoiding serious problems like bleeding, infection, or stroke. Participants will be followed for 30 days after the pump is placed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

advanced heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED HEART FAILURE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bayside Health
RECRUITING

Melbourne, Victoria, 3004, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
St Vincent's Hospital Sydney
RECRUITING

Sydney, New South Wales, 2010, Australia